Mauck Karen F, Clarke Bart L
Division of General Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Mayo Clin Proc. 2006 May;81(5):662-72. doi: 10.4065/81.5.662.
Osteoporosis is the most common bone disease in humans and affects both men and women. The clinical and public health implications of the disease are substantial because of the mortality, morbidity, and cost of medical care associated with osteoporotic fractures. Osteoporosis is diagnosed on the basis of a low-impact or fragility fracture or low bone mineral density, which was best assessed by central dual-energy x-ray absorptiometry. Both nonpharmacological therapy (calcium and vitamin D supplementation, weight-bearing exercise, and fall prevention) and pharmacological treatments (antiresorptive and anabolic agents) may be helpful in the prevention and treatment of osteoporosis. Therefore, clinicians need to be vigilant in instituting primary prevention measures for those at high risk for osteoporosis and in instituting treatment for patients diagnosed as having the disease either by screening or a history of fracture. This article provides an overview of the diagnosis, screening, prevention, and treatment of osteoporosis.
骨质疏松症是人类最常见的骨病,影响男性和女性。由于骨质疏松性骨折相关的死亡率、发病率和医疗费用,该疾病对临床和公共卫生具有重大影响。骨质疏松症是根据低冲击力或脆性骨折或低骨矿物质密度来诊断的,这最好通过中央双能X线吸收法进行评估。非药物治疗(补充钙和维生素D、负重运动以及预防跌倒)和药物治疗(抗吸收和促合成药物)都可能有助于预防和治疗骨质疏松症。因此,临床医生需要警惕为骨质疏松症高危人群采取一级预防措施,并为通过筛查或骨折病史被诊断患有该疾病的患者进行治疗。本文概述了骨质疏松症的诊断、筛查、预防和治疗。